EP4213929A1 - Électrode plane pour biocapteurs réalisée au moyen d'une géométrie fractale répétitive - Google Patents
Électrode plane pour biocapteurs réalisée au moyen d'une géométrie fractale répétitiveInfo
- Publication number
- EP4213929A1 EP4213929A1 EP21806053.1A EP21806053A EP4213929A1 EP 4213929 A1 EP4213929 A1 EP 4213929A1 EP 21806053 A EP21806053 A EP 21806053A EP 4213929 A1 EP4213929 A1 EP 4213929A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- electrode
- geometry
- fractal
- repetitive
- electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003252 repetitive effect Effects 0.000 title claims abstract description 22
- 239000000919 ceramic Substances 0.000 claims abstract description 16
- 239000000758 substrate Substances 0.000 claims abstract description 15
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052737 gold Inorganic materials 0.000 claims abstract description 8
- 239000010931 gold Substances 0.000 claims abstract description 8
- 238000007650 screen-printing Methods 0.000 claims abstract description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052709 silver Inorganic materials 0.000 claims abstract description 6
- 239000004332 silver Substances 0.000 claims abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 5
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 238000005245 sintering Methods 0.000 claims description 5
- 239000000427 antigen Substances 0.000 claims description 4
- 108091007433 antigens Proteins 0.000 claims description 4
- 102000036639 antigens Human genes 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- 239000003792 electrolyte Substances 0.000 claims description 2
- 239000011888 foil Substances 0.000 claims description 2
- 229910052573 porcelain Inorganic materials 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 21
- 238000007306 functionalization reaction Methods 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 238000013461 design Methods 0.000 abstract description 6
- 108020004414 DNA Proteins 0.000 description 16
- 238000001514 detection method Methods 0.000 description 14
- 238000010276 construction Methods 0.000 description 13
- 239000003298 DNA probe Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000012491 analyte Substances 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N methyl alcohol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- GWOLZNVIRIHJHB-UHFFFAOYSA-N 11-mercaptoundecanoic acid Chemical compound OC(=O)CCCCCCCCCCS GWOLZNVIRIHJHB-UHFFFAOYSA-N 0.000 description 5
- 241000589875 Campylobacter jejuni Species 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 4
- 108020003215 DNA Probes Proteins 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000003475 lamination Methods 0.000 description 4
- 229960000907 methylthioninium chloride Drugs 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 239000002824 redox indicator Substances 0.000 description 4
- 108091023037 Aptamer Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 238000002484 cyclic voltammetry Methods 0.000 description 3
- 238000000835 electrochemical detection Methods 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 229940072221 immunoglobulins Drugs 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 238000004626 scanning electron microscopy Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- XEIPQVVAVOUIOP-UHFFFAOYSA-N [Au]=S Chemical compound [Au]=S XEIPQVVAVOUIOP-UHFFFAOYSA-N 0.000 description 1
- 239000007825 activation reagent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 229920000592 inorganic polymer Polymers 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
- G01N27/3277—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a redox reaction, e.g. detection by cyclic voltammetry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/48—Systems using polarography, i.e. measuring changes in current under a slowly-varying voltage
Definitions
- the invention in general, covers the field of electrochemistry with a special accent on the specific realization of the biosensor electrode.
- the biosensor realized as such has potential applications in the detection of pathogenic microorganisms in contaminated food and water, i.e. nucleic acids and proteins in the sample; then in biomedicine, in the detection of tumor markers, hormones, etc.
- the area of classification is wide and covers the following classes: C12Q1, G01N27, A61B5/0408, H05K1/0283, A61N1/05, and H01L23.
- the invention talks about the new construction of an electrochemical planar biosensor whose electrodes are realized using repetitive fractal geometry.
- the invention solves the problem of insufficient sensitivity of electrochemical sensors, which is especially important in the realization of biosensors intended for detection of biological markers or pathogens present in traces (in small quantities) in a contaminated sample in a way that new construction of repetitive geometry (specifically fractal) increases sensor sensitivity.
- the invention contributes to the increase of sensitivity, because it enables a change in the design of the electrode of the biosensor and not an additional modification of the material from which the electrodes are made.
- Patent US20060068381 titled “Methods for identifying a peptide that binds a geometrical shape” published on March 30, 2006, describes a new technique for immobilizing antibodies, enzymes, or aptamers on the surface of a sensor electrode, but it differs from the mentioned invention, in the way how the electrode is realized.
- Patent KR20190104041 A titled “Electrophoresis chip for electrophoretic applications” published on September 5, 2019, generally describes a set of printed electrodes with symmetrical geometry that use the electrochemical detection method for application in electrophoresis, but like the previous solution, it differs significantly from the invention in the way how the electrode is realized.
- Patent EP1931248B1 titled “Biologically integrated electrode devices” published on June 18, and patent US20190030318A, titled “Fractal geometry microelectrodes and uses thereof’ published January 31, 2019.
- the above- mentioned patents are focused on the application of electro active, i.e. conductive polymers within the sensor, without considering specific geometries in the electrode construction.
- the mentioned applications refer to implantable pulse generators for stimulation of the nervous system and do not imply the use of bioreceptors.
- Patent US20150380355A1 titled “Self-similar and fractal design for stretchable electronics” published on December 31, 2015, describes the application of fractals in the realization of electronic connections in flexible electronics, but does not involve the application regarding the realization of electrochemical sensors or biosensors.
- Patent US8009053B2 titled “Rain sensor with fractal capacitor(s)” published on September 10, 2009, explains the realization of a capacitive sensor using fractal geometry, but not in accordance with the description of the invention.
- Patent JP2016520986 A titled “Self-similar fractal design for stretchable electronics” published on July 14, 2016, belongs to the state-of-the-art but does not mention that fractal geometry was applied to the planar electrode of the biosensor.
- Patent ES2517919T3 titled “Nanostructured microelectrodes and biodetection devices that incorporate them” published on November 4, 2014, describes the realization of nano structured electrodes in the form of wires for biosensor applications that can be made in the form of three-dimensional fractal structures, but the principle or description how the structure is realized is not mentioned.
- biosensors are one of the most commonly used technological solutions in various fields of rapid diagnostics, such as medicine, agriculture, food industry, environmental protection and biology. Unlike classical methods of microbiological analysis which are slow (several hours to one week to get results), expensive (based on several stages, using larger amounts of chemicals and equipment) and require highly trained researchers to apply them and interpret the results, biosensors enable fast, simple and specific analysis at a low cost.
- the main condition for the successful commercialization of biosensors is a sufficiently sensitive level of detection to be able to directly apply the sensor for analysis of contaminated samples (food, blood and blood plasma, water, or plant material).
- Typical planar electrochemical sensors consist of a working electrode, an auxiliary electrode, and a reference electrode, interconnected by a thin layer of electrolyte containing an analyte (detection target). Due to the specifics of the applicability, different types of electrochemical biosensor electrodes are known today in terms of the materials from which they are made, but the circular geometry of the working electrode is mainly used, which leads to limitations in terms of detection and sensitivity. The sensitivity of the biosensor largely depends on the material from which the electrodes are made, the substrate and the geometric parameters of the electrode.
- metals such as gold, silver or platinum in combination with ceramics or porcelain substrates are mostly used in the construction of electrodes since these materials offer relatively easy functionalization by biological molecules (DNA probes, antibodies, enzymes, aptamers, liposomes, etc.).
- the invention is based on the idea that the sensory characteristics of biosensors, in terms of sensitivity and limit of detection, can be significantly increased by changes in the geometry of the electrodes, without either changes in the material from which the electrodes are made or their additional functionalization.
- the invention proposes the realization of the mentioned biosensor electrode, i.e. the design of its new geometric construction. It is a system of three electrodes consisting of a working, reference and auxiliary electrode which are structurally realized using a repeating fractal geometry of the first order, although the invention provides a range up to the third order of the repeating geometry.
- the realization of the invention includes repetitive geometry of the 1 st order of the Sierpine fractal, but the invention also relates to the repetitive geometry of the Koch curve, Pean curve and Hilbert curve, and of the geometric shapes includes the three most common shapes - square, circle, and triangle.
- the application of repetitive geometry of fractal curves in the realization of biosensors is the basic innovation of the invention since it directly increases the sensitivity of electrochemical biosensors.
- the planar electrode is realized using a technology of Low-Temperature Cofired Ceramics (LTCC), where the base on which the electrode is realized is ceramic.
- LTCC Low-Temperature Cofired Ceramics
- a gold paste in the geometric shape of a fractal curve is applied to the nonsintered ceramic substrate by screen printing, over a previously prepared mask.
- the invention also includes platinum paste, carbon paste, and silver paste. Ceramic non-sintered strips 300 pm thick are initially cut and shaped with a laser, and after printing they are laminated and baked at 865 °C into highly electrically conductive electrodes, due to the sintering of the ceramic substrate itself and due to the sintering of the conductive paste. The process of lamination of several ceramic 1 -3 mm thick strips takes place in a uniaxial isothermal press at a temperature of 75 °C.
- the invention electrode itself is not limited to the electrode fabrication technology and includes the fabrication of electrodes using inkjet printing, or the use of other thin-film or thick-layer fabrication technologies, as well as fabrication on other substrates such as paper, glass, organic, and inorganic polymers.
- the planar electrode can be functionalized by various bioreceptors, such as single-stranded fragments, i.e. nucleic acid oligonucleotides (DNA and RNA probes) and antibodies, aptamers, lectins or enzymes. Bioreceptors are selected to be specific and selective for the required analyte. If functionalization is performed with antibodies, i.e. immunoglobulins, the resulting biosensor is the so-called immunosensor. Functionalization using DNA probes results in a genosensor.
- bioreceptors such as single-stranded fragments, i.e. nucleic acid oligonucleotides (DNA and RNA probes) and antibodies, aptamers, lectins or enzymes. Bioreceptors are selected to be specific and selective for the required analyte. If functionalization is performed with antibodies, i.e. immunoglobulins, the resulting biosensor is the so-called immunosensor. Functionalization using DNA probes results in
- FIG 1 shows the making process of an innovative biosensor electrode
- Figure 2 shows an innovative geometric layout of a biosensor electrode according to the description of the invention
- Figure 3 shows the innovative electrode - after fabrication: a) layout of the fabricated electrode, b) measured dimensions of the electrode, c) SEM (scanning electron microscopy) view of the gold electrode surface magnified 2000 times.
- Figure 4 shows the current-voltage characteristic of the realized biosensor
- Figure 4a and 4b show standard tests with a solution of 0.1 M ferrocenemethyl alcohol in 0.9M phosphate buffer and ImM ferrocene-methyl alcohol in 0.05M sulfuric acid, respectively, at a scan / ratio of 50 mV/s.
- Figure 4c) shows the current- voltage characteristic for 1 mM ferrocene-methyl alcohol in 0.05M sulfuric acid for different values of the scan ratio, while Figure 4d) shows the repeatability of the measurement results at different electrodes.
- Figure 5 shows a genosensor, i.e.
- a biosensor functionalized using specific DNA probes and its testing for the detection of different concentrations of DNA molecules isolated from Campylobacter jejuni, where a signal is generated when DNA sequences isolated from bacteria bind, i.e. hybridize to a specific DNA probe on the electrode surface of the invention.
- FIG. 6 shows the immunosensor, i.e. the testing of the immunosensor for different protein concentrations. Namely, it is a procedure of realization of the biosensor electrode, where the surface of the electrode is functionalized by applying immunoglobulins, i.e. antibodies specific for the protein (antigen) to be detected - in this case the antigen is a GST protein, and an anti-GST antibody is applied. The signal is generated when the GST protein binds to the anti-GST antibody applied to the electrode, which achieves electrochemical detection of the presence of GST protein in the sample, using ferrocene - redox indicator, which is in solution.
- immunoglobulins i.e. antibodies specific for the protein (antigen) to be detected - in this case the antigen is a GST protein, and an anti-GST antibody is applied.
- the signal is generated when the GST protein binds to the anti-GST antibody applied to the electrode, which achieves electrochemical detection of the presence of GST protein in the sample, using ferrocene -
- Figure 7 shows a comparison of the sensitivity of realized genosensors and immunosensors for the detection of Campylobacter jejuni and GST proteins in milk, respectively, as an example of the invention and a comparison with commercial sensors using circular geometry functionalized using the same electrode immobilization procedure.
- Figure 8 is an example of repetitive geometry for the present invention when it comes to successive repetition of circular geometry.
- the innovative biosensor electrode consists of three electrodes whose main feature of innovation is given in the new geometric construction of the working electrode in the form of a fractal curve.
- the construction which the invention proposes is a construction of repeating geometry of fractal shape in order to improve the sensitivity of the sensor itself, while other electrodes follow the geometry of the working electrode. In this way, the effective area between the working and auxiliary electrodes is increased.
- the invention starts from the hypothesis that the sensitivity of the biosensor can be significantly increased by changing the geometry of the electrodes without changing the material from which the electrodes are made.
- the invention itself includes a repetitive geometry of the 1st order of the Sierpine fractal, with dimensions shown in Figure 2, but the invention also relates to the repetitive geometry of the Koch curve, Pean curve and Hilbert curve, and of the geometric shapes includes the three most common shapes - square, circle, and triangle.
- the application of repetitive geometry of fractal curves in the realization of biosensors represents the main innovation of the invention because it directly increases the sensitivity of electrochemical biosensors.
- Figure 1 shows the process of making a sensor that begins with phase 101 where the selection of fractal geometry, fractal order, and electrode dimensions takes place, followed by phase 102 of making screen printing masks that are realized using photo-sensitive foil.
- the planar electrode is realized by the technology of Low-temperature Cofired Ceramics (LTCC), where the substrate on which the electrode is realized is ceramic.
- LTCC Low-temperature Cofired Ceramics
- phase 100 ceramic non-sintered strips 300 pm thick are first cut and shaped with a laser.
- phase a gold paste manufactured by Heraeus TC7102 in the geometric shape of a fractal curve is applied to the cut non-sintered ceramic substrate by a screen-printing process, over a previously prepared mask.
- the invention also includes platinum paste, carbon paste, and silver paste.
- phase 104 In order to ensure the mechanical strength of the electrode in phase 104, a process of lamination of several unsintered ceramic strips of 3-7 layers is performed in order to achieve a final electrode thickness of 1-2 mm. Lamination is performed in an isothermal uniaxial press at a temperature of 75 °C for 3 minutes. The lamination is followed by phase 105, firing at a temperature of 865 °C for 10 hours, due to the sintering of the ceramic substrate itself and the sintering of the conductive paste in high-conductivity electrodes.
- Repetitive geometry is realized through fractal curves whose basic characteristic is to fill the assigned space in a highly efficient way, i.e. as the order of the fractal curve grows, it changes so that its dimension increases on a limited area. Therefore, the use of such a construction contributes that the effective area between the working and auxiliary electrodes is increases 2.4 times.
- the system of three electrodes which is the basis of the biosensors which invention proposes, is realized so that the working electrode provides potential variation, auxiliary (counter) electrode balances the current of the working electrode, and the reference has a known potential so that the principle of the system is to control potential, the voltage in contact with the analytical substance while measuring the change in current.
- the reference electrode is half a cell with a known reduction potential. Its only role is to act as a reference in measuring and controlling the working electrode potential.
- the fractal curves that the invention includes are Koch's curve, Sierpine fractal triangle, and carpet, Pean's and Hilbert's curve.
- the invention also uses a square, triangle and circle, whose scaled copies are periodically repeated, as a starting point for forming the fractal geometry of the biosensor electrode, where a set of parameters such as initial dimensions, scaling factors, fractal order, i.e. number of iterations of scaled copies, etc.
- the example of a circle best explains the importance of repetitive geometry in the application of biosensors.
- Figure 8 presents the repeating geometry of the circle, where the second iteration suggests a number of parameters: the number of repetitions of the circle, the distance of small and large circles, and the scaling factor, i.e. the ratio of the diameter of the small and large circle.
- Figure 2 shows a biosensor consisting of an innovative electrode construction consisting of a working, auxiliary and reference electrode with appropriate dimensions.
- the invention does not limit the dimensions of the electrode, but primarily emphasizes the dimensions below and the range of dimensions.
- Figure 2 shows the appearance of the electrodes, as well as the initial dimensions of the sensor.
- Figure 3 shows the realized innovative electrode, an enlarged view of the surface of the realized electrode, as well as the measured dimensions of individual parts of the realized electrode.
- Figure 4 shows the current-voltage characteristics of sensors tested using cyclic voltammetry.
- Figures 4a and 4b show standard assays with a solution of 0.1 M ferrocene-methyl alcohol in 0.9M phosphate buffer and 1 mM ferrocene-methyl alcohol in 0.05M sulfuric acid, at a scan rate of 50 mV/s, respectively.
- Figure 4c shows the current-voltage characteristic for 1 mM ferrocene-methyl alcohol in 0.05M sulfuric acid at different values of the scan ratio, while Figure 4d shows the repeatability of the measurement results at different electrodes.
- the planar fractal electrode can be functionalized with various bioreceptors, such as antibodies or single-stranded DNA probes, i.e. deoxyribonucleic acid oligonucleotides. Bioreceptors are selected to be specific and selective for the required analyte. If functionalization is performed with antibodies, i.e. immunoglobulins, the resulting biosensor is the so-called immunosensor. Functionalization through DNA testing resulted in a genosensor. The potential of developed planar electrodes for practical applications has been tested in two types of biosensor applications, genosensors and immunosensors.
- bioreceptors such as antibodies or single-stranded DNA probes, i.e. deoxyribonucleic acid oligonucleotides. Bioreceptors are selected to be specific and selective for the required analyte. If functionalization is performed with antibodies, i.e. immunoglobulins, the resulting biosensor is the so-called immunosensor. Functionalization through DNA
- DNA probe is a single-stranded oligonucleotide with a nucleotide sequence complementary to the targeted sequence of nucleotides in the analyte.
- DNA probes specific for Campylobacter jejuni were used.
- DNA bioreceptor i.e. the probe was functionalized with thiol group on its 5 ’-end, since this allows gold-sulphur covalent bonding of the probe to the gold on the electrode surface.
- MB phosphate buffer
- Functionalized electrodes were then washed three times with phosphate buffer (PBS) in order to remove all DNA molecules non-covalently bound to the surface.
- Methylene blue (MB) at 2 pg ml-1 in PBS was then applied to the surface for 1 hour to enable testing for DNA immobilization and hybridization.
- MB is a frequently used redox indicator for electrochemical measurements with genosensors, for detection of DNA hybridization since it has different electrochemical response to the single-stranded DNA i.e. single oligonucleotides and double-stranded DNA i.e. helices obtained by complementary binding of the probe and sample nucleotides. The difference stems from the interaction of MB with guanidine base in single-stranded DNA.
- the efficacy of DNA probe immobilization and hybridization were tested by cyclic voltammetry. Measurements were conducted between -0.3 and +0.6 vs. silver/silver chloride (Ag/AgCL) reference electrode, at 100 mV s-1 in PBS, pH 7.2 at room temperature. The efficiency was evaluated by comparing CV results obtained using complementary and non-complementary sequences. The CV values are proportional to the hybridization of the DNA molecules.
- Figure 5 a shows schematics of immobilization of the DNA nucleotides specific for Campylobacter jejuni bacterium onto the electrode of the innovation.
- Figures 5b and 5c show results of tests with different concentration for positive and negative test control probe, while Figure 5d shows microstructure of the electrode obtained by Scanning Electron Microscopy (SEM) of the electrode functionalized with DNA.
- SEM Scanning Electron Microscopy
- the solution of monoclonal antibody in phosphate buffer is applied onto the MUA-layered surface of the electrode, followed by incubation of Ih on room temperature to enable formation of the amide bonds between the applied antibody and the MUA layer.
- the electrodes modified with antibody were sequentially rinsed with PBS buffer, pH 7.2. All biofunctionalized electrodes were kept wet at 4°C before utilization to avoid antibody denaturation. Before measurements, the remaining active sites of biofunctionalized electrodes were neutralized with 50 mM ethanolamine in PBS buffer for 30 min at room temperature, then rinsed with PBS without drying.
- the electrochemical measurements with electrodes functionalized with antibodies are performed in solution of 0.1M ferrocene-methanol in 0.9M PBS - ferrocene is a redox indicator and generates electrochemical signal.
- the ferrocene-generated signals changes, which is detected by cyclic voltammetry.
- Figure 6 shows the method of realizing a biosensor electrode as an immunosensor, where the electrode has been functionalized with a specific antibody, in this case the monoclonal anti-GST antibody.
- Figure 6a schematically shows the process of antibody immobilization at the surface of the electrode, while Figure 6b shows testing for different concentrations of GST protein.
- Figure 6c shows testing using real milk samples.
- Figure 6d shows an enlarged SEM image of the electrode’s surface with GST proteins from milk, bound to the antibodies on the electrode’s surface.
- GST was used as a model protein to check the efficiency of the sensor. Measurements were performed in an aqueous solution (phosphate buffer -PBS) and in milk to demonstrate that the electrode could be used directly for the analysis of contaminated food (milk). In both cases, ferrocene is added to the sample solution as a redox indicator.
- Figure 7 shows the sensitivity of the realized innovative sensors and the comparison of the characteristics with the test results on the circular electrode realized on the same surface. The comparison was performed for both types of sensors, i.e. both for the genosensor and the immunosensor. It can be noticed that the sensitivity is increased more than 5 times in relation to the circular geometry.
- Biosensors are used in various fields where rapid diagnostics and field applications are required, in food production and storage processes and other aspects of food technology, as well as in biomedicine and in the monitoring of environmental parameters, etc. Commercialization depends on sensitivity, since samples for analysis usually contain small concentrations of analyte (biomarkers).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Food Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
L'invention concerne une électrode plane pour biocapteurs réalisée par application d'une géométrie fractale répétitive fournissant une nouvelle façon de construire un système de trois électrodes de biocapteur au moyen de la géométrie fractale répétitive jusqu'au niveau de troisième ordre. La réalisation de l'invention comprend une géométrie répétitive de 1er ordre de la géométrie fractale de Sierpinski, mais l'invention a également trait à la géométrie répétitive de la courbe de Koch, la courbe de Péan et la courbe de Hilbert, et des formes géométriques comprenant les trois formes les plus communes carrées, circulaires et triangulaires. La géométrie répétitive est la base de l'aspect innovant de l'invention, étant donné que le changement dans conception de l'électrode plane avec ses paramètres, qui sera discuté dans la description détaillée, ainsi que l'ordre des fractales, contribue de manière significative à la sensibilité accrue des biocapteurs. Le biocapteur selon l'invention est réalisé par technologie LTCC et la sérigraphie, c'est-à-dire pour le substrat à partir duquel a été réalisée l'électrode de biocapteur, de la céramique est utilisée sur laquelle de l'or est appliqué par sérigraphie, bien que l'invention comprenne de l'argent, du platine et des pâtes de carbone, mais également d'autres technologies de fabrication ainsi que des matériaux de substrat et une fonctionnalisation supplémentaire des surfaces d'électrode. Sur des bandes céramiques non frittées découpées au laser au moyen du procédé d'impression sérigraphique, grâce à des masques conçus spécifiquement au moyen d'une procédure photographique, une pâte conductrice est appliquée sous une forme fractale innovante. Les bandes non frittées sont ensuite laminées pour une résistance mécanique et cuites au four pour le processus de frittage de la pâte et du substrat lui-même. Les électrodes peuvent ensuite être fonctionnalisées avec des biorécepteurs appropriés, qui n'affectent pas la sensibilité elle-même, mais la spécificité de la reconnaissance d'analytes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RS20201065A RS20201065A1 (sr) | 2020-09-04 | 2020-09-04 | Planarna elektroda za biosenzore realizovana primenom ponavljajuće fraktalne geometrije |
PCT/RS2021/000011 WO2022050860A1 (fr) | 2020-09-04 | 2021-08-30 | Électrode plane pour biocapteurs réalisée au moyen d'une géométrie fractale répétitive |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4213929A1 true EP4213929A1 (fr) | 2023-07-26 |
Family
ID=78592902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21806053.1A Pending EP4213929A1 (fr) | 2020-09-04 | 2021-08-30 | Électrode plane pour biocapteurs réalisée au moyen d'une géométrie fractale répétitive |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4213929A1 (fr) |
RS (1) | RS20201065A1 (fr) |
WO (1) | WO2022050860A1 (fr) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050147964A1 (en) | 2003-12-30 | 2005-07-07 | Intel Corporation | Methods for identifying a peptide that binds a geometrical shape |
US8005526B2 (en) | 2005-08-31 | 2011-08-23 | The Regents Of The University Of Michigan | Biologically integrated electrode devices |
US7551094B2 (en) | 2006-01-10 | 2009-06-23 | Guardian Industries Corp. | Rain sensor with fractal capacitor(s) |
JP5712129B2 (ja) | 2008-09-02 | 2015-05-07 | ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント | ナノ構造化微小電極およびそれを組み込んだバイオセンシング装置 |
WO2012109157A2 (fr) | 2011-02-07 | 2012-08-16 | The Governing Council Of The University Of Toronto | Biosondes et procédés d'utilisation de celles-ci |
JP2016520986A (ja) | 2013-02-06 | 2016-07-14 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ | 伸縮性エレクトロニクス用の自己相似フラクタルデザイン |
US9613911B2 (en) | 2013-02-06 | 2017-04-04 | The Board Of Trustees Of The University Of Illinois | Self-similar and fractal design for stretchable electronics |
KR20160034246A (ko) * | 2013-07-24 | 2016-03-29 | 캘리포니아 인스티튜트 오브 테크놀로지 | 주입가능한 완전히 통합된 전기화학 센서들의 설계 및 제조 |
WO2015157855A1 (fr) * | 2014-04-15 | 2015-10-22 | Gandhi Harry | Lentille de contact fonctionnelle et systèmes et procédés associés |
US20160235347A1 (en) * | 2015-02-13 | 2016-08-18 | Maarij Baig | Artificial sensors and methods of manufacture thereof |
WO2018122852A1 (fr) | 2016-12-29 | 2018-07-05 | Schnell Amit | Cartouche devant être utilisée dans des diagnostics in vitro, et procédé d'utilisation associé |
US20190030318A1 (en) | 2017-07-27 | 2019-01-31 | Purdue Research Foundation | Fractal geometry microelectrodes and uses thereof |
-
2020
- 2020-09-04 RS RS20201065A patent/RS20201065A1/sr unknown
-
2021
- 2021-08-30 EP EP21806053.1A patent/EP4213929A1/fr active Pending
- 2021-08-30 WO PCT/RS2021/000011 patent/WO2022050860A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
RS20201065A1 (sr) | 2022-03-31 |
WO2022050860A1 (fr) | 2022-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Blair et al. | A review of microfabricated electrochemical biosensors for DNA detection | |
Karunakaran et al. | Introduction to biosensors | |
K'Owino et al. | Impedance spectroscopy: a powerful tool for rapid biomolecular screening and cell culture monitoring | |
EP1423688B1 (fr) | Procedes de production de capteurs potentiometriques a haute sensibilite | |
Das et al. | An electrochemical genosensor for Salmonella typhi on gold nanoparticles-mercaptosilane modified screen printed electrode | |
CN101126734B (zh) | 基于核酸适体修饰导电聚合物的生物传感器及其制备方法和用途 | |
US20100006451A1 (en) | Biosensing device and method for detecting target biomolecules in a solution | |
Li et al. | Impedance labelless detection-based polypyrrole protein biosensor | |
Li et al. | Aptamer biosensor for label-free square-wave voltammetry detection of angiogenin | |
US6063259A (en) | Microfabricated thick-film electrochemical sensor for nucleic acid determination | |
Yu et al. | An impedance array biosensor for detection of multiple antibody–antigen interactions | |
Laschi et al. | Planar electrochemical sensors for biomedical applications | |
EP2362941A1 (fr) | Dispositif biocapteur et procédé de détection de biomolécules cibles dans une solution | |
WO2009122159A2 (fr) | Biodétecteur pour une détection d'analyte | |
CN110186975B (zh) | 用于食源性微生物检测的微液滴电化学传感器及制备方法 | |
Ferreira | Electrochemical nano (bio) sensors: advances, diagnosis and monitoring of diseases Rodrigo Michelin Iost1, Welter Cantanhede da Silva2, Joao Marcos Madurro3, Ana Graci Brito Madurro4, Lucas Franco | |
CA2432864A1 (fr) | Methode de detection par mesure de l'impedance d'une ou plusieurs substances a analyser dans un echantillon, et dispositif connexe | |
Manring et al. | Recent advances in electrochemical tools for virus detection | |
Shi et al. | Immunoassays based on microelectrodes arrayed on a silicon chip for high throughput screening of liver fibrosis markers in human serum | |
Bigdeli et al. | Electrochemical impedance spectroscopy (EIS) for biosensing | |
Houssin et al. | Electrochemical detection | |
Aydın et al. | Label-free and reagent-less electrochemical detection of nucleocapsid protein of SARS-CoV-2: An ultrasensitive and disposable biosensor | |
Chuang et al. | Label-free impedance biosensors for Point-of-Care diagnostics | |
WO2018176042A1 (fr) | Immunocapteurs électrochimiques | |
Ferrario et al. | Development of a disposable gold electrodes-based sensor for electrochemical measurements of cDNA hybridization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230317 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |